Literature DB >> 2435401

Malignant mixed müllerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations.

K R Geisinger, D J Dabbs, R B Marshall.   

Abstract

In the female genital tract, malignant mixed müllerian tumors (MMTs) are uncommon neoplasms of uncertain histogenesis. We have examined 11 MMTs by both electron microscopy (EM) and immunoperoxidase techniques (IPX). Eight were of endometrial, two were of ovarian, and one of tubal origins. The IPX analysis included monoclonal antibodies to keratin (k) and vimentin (v) and a polyclonal antibody to myoglobin. Carcinomatous elements were always keratin positive (K+) and were focally positive for vimentin in six tumors. Homologous stromal sarcoma cells were vimentin positive (V+) and in three tumors were focally K+. Ultrastructurally, the epithelial cells were not highly differentiated and the sarcomatous elements generally resembled normal proliferative-phase stromal cells. The epithelial and stromal elements were separated by a thin basal lamina that only rarely and focally had discontinuities. No transitional cellular forms were identified. A definite positive myoglobin reaction was seen in two of the four neoplasms in which rhabdomyoblasts were identified by light microscopy. Myofilaments were identified by electron microscope in three neoplasms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435401     DOI: 10.1002/1097-0142(19870515)59:10<1781::aid-cncr2820591017>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship.

Authors:  Laura Ardighieri; Luigi Mori; Sara Conzadori; Mattia Bugatti; Marcella Falchetti; Carla Maria Donzelli; Antonella Ravaggi; Franco E Odicino; Fabio Facchetti
Journal:  Virchows Arch       Date:  2016-04-08       Impact factor: 4.064

2.  Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary.

Authors:  J L Becker; P R Papenhausen; R H Widen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

3.  Three-dimensional culture of a mixed mullerian tumor of the ovary: expression of in vivo characteristics.

Authors:  T J Goodwin; T L Prewett; G F Spaulding; J L Becker
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

Review 4.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

5.  Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.

Authors:  Chelsea Bolyard; Ji Young Yoo; Pin-Yi Wang; Uksha Saini; Kellie S Rath; Timothy P Cripe; Jianying Zhang; Karuppaiyah Selvendiran; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

6.  Histogenesis of ovarian malignant mixed mesodermal tumours.

Authors:  T J Clarke
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

7.  Carcinosarcoma of the urinary bladder. A light, immunohistochemical and electron microscopical case report.

Authors:  P A Cross; B P Eyden; V M Joglekar
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.

Authors:  Susana M Campos; William E Brady; Katherine M Moxley; Roisin E O'Cearbhaill; Paula S Lee; Paul A DiSilvestro; Jacob Rotmensch; Peter G Rose; Premal H Thaker; David M O'Malley; Parviz Hanjani; Rosemary E Zuna; Martee L Hensley
Journal:  Gynecol Oncol       Date:  2014-03-01       Impact factor: 5.482

9.  Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.

Authors:  Alexander Schipf; Doris Mayr; Thomas Kirchner; Joachim Diebold
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

10.  Rapidly growing esophageal carcinosarcoma reduced by neoadjuvant radiotherapy alone.

Authors:  Naotaka Ogasawara; Yasuhiro Tamura; Yasushi Funaki; Yoshiharu Yamaguchi; Akihiro Shimozato; Kenichiro Yanamoto; Emiko Takahashi; Masahiko Miyachi; Makoto Sasaki; Kunio Kasugai
Journal:  Case Rep Gastroenterol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.